ERCC1 as a Predictive Marker for FOLFOX Chemotherapy in an Adjuvant Setting

PURPOSE: The purpose of this study was to identify the excision repair cross-complementation group 1 (ERCC1) as a predictive marker for FOLFOX adjuvant chemotherapy in stages II and III colon cancer patients. METHODS: A total of 166 high risk stages II and III colon cancer patients were retrospectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Chee Young, Seo, Sang Hyuk, An, Min Sung, Kim, Kwang Hee, Bae, Ki Beom, Hwang, Jin Won, Kim, Ji Hyun, Kim, Bo Mi, Kang, Mi Seon, Oh, Min Kyung, Hong, Kwan Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Coloproctology 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496459/
https://www.ncbi.nlm.nih.gov/pubmed/26161376
http://dx.doi.org/10.3393/ac.2015.31.3.92

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496459/
https://www.ncbi.nlm.nih.gov/pubmed/26161376
http://dx.doi.org/10.3393/ac.2015.31.3.92

Ejemplares similares